{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1608"}, "official-title": {"#tail": "\n\t", "#text": "To require the Secretary of Health and Human Services to\n\t\t  promulgate regulations regarding the authorship, content, format, and\n\t\t  dissemination of Patient Medication Information to ensure patients receive\n\t\t  consistent and high-quality information about their prescription medications\n\t\t  and are aware of the potential risks and benefits of prescription\n\t\t  medications."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130417", "#text": "April 17, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced\n\t\t\t the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Owens", "@name-id": "O000169"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H00ADAB20FC0A4586B37C305C7575E8F8", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Cody Miller Initiative for Safer\n\t\t\t Prescriptions Act"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HB773DC02B2C54AFAB6E4E27455B9C893"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t the following:", "@entity-type": "act", "#text": "section 505D", "@value": "Federal Food, Drug, and Cosmetic Act/s:505D"}, "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Chapter V of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq.", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Patient\n\t\t\t medication information for prescription drugs"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "505E."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Patient\n\t\t\t\tmedication information for prescription drugs"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue regulations regarding the authorship,\n\t\t\t\tcontent, format, and dissemination requirements for patient medication\n\t\t\t\tinformation (referred to in this section as ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "section 503(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}], "term": {"#tail": ") for drugs subject\n\t\t\t\tto ", "#text": "PMI"}, "#text": "Not later than 2 years after the date of enactment of\n\t\t\t\tthis section, the "}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n            ", "@id": "HEEA084337D004A22B04DCBC96A7DDA2E"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall require that the PMI with\n\t\t\t\trespect to a drug\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E/ss:a", "@proposed": "true"}, "#text": "The\n\t\t\t\tregulations promulgated under "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Content"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "be scientifically\n\t\t\t\taccurate and based on the professional labeling approved by the Secretary and\n\t\t\t\tauthoritative, peer-reviewed literature; and"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H9B2ED450473C43BDA6334CD902EE7525", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "includes\n\t\t\t\tnontechnical, understandable, plain language that is not promotional in tone or\n\t\t\t\tcontent, and contains at least\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "HEE0486A2048544BCBAF46925A5B02DA1", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") and as a drug that is the subject of an\n\t\t\t\tapproved abbreviated new drug application under ", "@entity-type": "act", "#text": "section 505(j)(2)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A"}, {"#tail": " or of an\n\t\t\t\tapproved license for a biological product submitted under ", "@entity-type": "act", "#text": "section 505(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ", if applicable;", "@entity-type": "act", "#text": "section 351(k) of the\n\t\t\t\tPublic Health Service Act", "@value": "Public Health Service Act/s:351/ss:k"}], "#text": "the established\n\t\t\t\tname of drug, including the established name of such drug as a listed drug (as\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HA1FED0A8CBD5482E9B30314A9359DCEE", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "drug uses and\n\t\t\t\tclinical benefits;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H27786D7739F847D7A7A842A73DF5D14E", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "general directions\n\t\t\t\tfor proper use;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HCE9D20F411F74398A54D1258E479C0CE", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "contraindications,\n\t\t\t\tcommon side effects, and most serious risks of the drug, especially with\n\t\t\t\trespect to certain groups such as children, pregnant women, and the\n\t\t\t\telderly;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H61AE7A0428EF4996A4F864C74C974D25", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "measures patients\n\t\t\t\tmay be able to take, if any, to reduce the side effects and risks of the\n\t\t\t\tdrug;"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H549590FA9B494C03ACAC795CDA0DFA8C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "when a patient\n\t\t\t\tshould contact his or her health care professional;"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "HD23F07B74B044319B10D15AC6E4166E8", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "instructions not\n\t\t\t\tto share medications, and, if any exist, key storage requirements, and\n\t\t\t\trecommendations relating to proper disposal of any unused portion of the drug;\n\t\t\t\tand"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "HA05BD0F26C8F4162AC00E1E12136C04C", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "known clinically\n\t\t\t\timportant interactions with other drugs and substances."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "HFAC505D67AB84501833FF023D484625B", "#text": "\n                "}]}], "#text": "\n            ", "@id": "HB6E2356BF3C94931BB9F312F6AC0B944"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include standards related to\u2014", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E/ss:a", "@proposed": "true"}, "#text": "The regulations promulgated under\n\t\t\t\t"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Timeliness,\n\t\t\t\tconsistency, and accuracy"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "performing timely\n\t\t\t\tupdates of drug information as new drugs and new information becomes\n\t\t\t\tavailable;"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H5FED5F0EF1614EB98268D9B4DD3238BE", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "ensuring that\n\t\t\t\tcommon information is applied consistently and simultaneously across similar\n\t\t\t\tdrug products and for drugs within classes of medications in order to avoid\n\t\t\t\tpatient confusion and harm; and"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HA4D6FACD290645DA9DD23A8421DBCF7B", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "developing a\n\t\t\t\tprocess, including consumer testing, to assess the quality and effectiveness of\n\t\t\t\tPMI in ensuring that PMI promotes patient understanding and safe and effective\n\t\t\t\tmedication use."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "HBD11F566DCD440D69E96BAFF9082F216", "#text": "\n              "}], "#text": "\n            ", "@id": "HEA1803EB3EC84E178D73C6EC60AA475E"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tprovide for the development of a publicly accessible electronic repository for\n\t\t\t\tall PMI documents and content to facilitate the availability of\n\t\t\t\tPMI.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505E/ss:a", "@proposed": "true"}, "#text": "The regulations promulgated under "}, "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n            ", "#text": "Electronic\n\t\t\t\trepository"}, "#text": "\n            ", "@id": "H30AFA2E286424FB7AFD0EDCCACFE0791"}], "#text": "\n          ", "@id": "HAD2253C6AC8B4BC6ABC6B665A642A1AC"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HA9C2307A2D2343038E053B46411D0F45"}, "#text": "\n      ", "@id": "H55F490FBB29C4F75BB748BB5443A3347"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall publish on the Internet Web site\n\t\t\t of the Food and Drug Administration a link to the Daily Med Web site\n\t\t\t (http://dailymed.nlm.nih.gov/dailymed) (or any successor Web site).", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Publication on\n\t\t\t internet Web site"}, "#text": "\n      ", "@id": "H3B6BE4D679DC487A92BAF9A062ACB5B4"}], "#text": "\n\t\t", "@id": "HA4BF7606683C44D696CAB59EE1712346"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-04-17"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1608 IH: Cody Miller Initiative for Safer Prescriptions Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}